Casdin Capital »

10x Genomics Inc Cl A shares owned by Casdin Capital

Quarter-by-quarter ownership of 10x Genomics Inc Cl A (TXG) shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in 10x Genomics Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including 10x Genomics Inc Cl A held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 10x Genomics Inc Cl A by Casdin Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $23M 1.4M 16.31

More positions owned by Casdin Capital

Genedx Holdings Corp Com Cl A (WGS)
Revolution Medicines (RVMD)
Biolife Solutions Com New (BLFS)
D Fluidigm Corp Del (LAB)
Relay Therapeutics (RLAY)
Structure Therapeutics Sponsored Ads (GPCR)
Illumina (ILMN)
Avidity Biosciences Ord (RNA)
Beam Therapeutics (BEAM)
Guardant Health (GH)
Maze Therapeatics (MAZE)
Denali Therapeutics (DNLI)
Alnylam Pharmaceuticals (ALNY)
Neurogene (NGNE)
10x Genomics Cl A Com (TXG)

View all positions for Casdin Capital

Top funds holding 10x Genomics Inc Cl A

Vanguard Group
ARK Investment Management
BlackRock
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Millennium Management
Quantinno Capital Management
Wellington Management Company
Goldman Sachs Group
Geode Capital Management
AQR Capital Management
Jacobs Levy Equity Management
State Street Corporation
Renaissance Technologies

View all funds holding 10x Genomics Inc Cl A